Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Rheumatology Reports

Issue 1/2009

Content (11 Articles)

Clinical Trials Report

Outcome of aspirin treatment of antiphospholipid antibody-positive patients

Kathleen M. O’Neil

The use of opioids in the treatment of osteoarthritis: When, why, and how?

Jeremy L. R. Goodwin, Jan J. Kraemer, Zahid H. Bajwa

The biomechanics of osteoarthritis: Implications for therapy

Joel A. Block, Najia Shakoor

WNT signaling in osteoarthritis and osteoporosis: What is the biological significance for the clinician?

Liesbet Lodewyckx, Rik J. U. Lories

Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs

Matthias Hermann

Aspirin and acetaminophen: Should they be available over the counter?

Kay Brune, Burkhard Hinz, Ivan Otterness

Antiphospholipid antibodies in rheumatoid arthritis: Identifying the dominoes

Debbie A. Gladd, Ewa Olech

Renal manifestations of the antiphospholipid syndrome

David D’Cruz

Atherosclerosis in autoimmune diseases

Eiji Matsuura, Kazuko Kobayashi, Luis R. Lopez

Neonatal effects of maternal antiphospholipid syndrome

Angela Tincani, Chiara Biasini Rebaioli, Laura Andreoli, Andrea Lojacono, Mario Motta

Mechanisms of antiphospholipid-induced thrombosis: Effects on the protein C system

Denis Wahl, Aurélie Membre, Christine Perret-Guillaume, Véronique Regnault, Thomas Lecompte

Dec 08
Issue: 6/2008
Apr 09
Issue: 2/2009

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits